1. Interferon β‐1a reduces increased interleukin‐16 levels in multiple sclerosis patients. (25th January 2014) Authors: Nischwitz, S.; Faber, H.; Sämann, P. G.; Domingues, H. S.; Krishnamoorthy, G.; Knop, M.; Müller‐Sarnowski, F.; Yassouridis, A.; Weber, F. Journal: Acta neurologica Scandinavica Issue: Volume 130:Number 1(2014:Jul.) Page Start: 46 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗